SMS Pharma successfully completes USFDA inspection at Telangana Central Laboratory Analytical Services
Written By : Ruchika Sharma
Medically Reviewed By : Dr. Kamal Kant Kohli
Published On 2025-06-26 03:45 GMT | Update On 2025-06-26 03:45 GMT
USFDA inspection
Advertisement
Telangana: SMS Pharma has announced the second successful completion of the United States Food and Drug Administration (USFDA) inspection at its Central Laboratory Analytical Services, located at, Gagillapur Village, Medchal Malkajgiri District, Hyderabad, Telangana.
The inspection, conducted from 23rd June 2025 to 25th June 2025, concluded with zero Form 483 observations.
An FDA Form 483 is issued to firm management at the conclusion of an inspection when an investigator(s) has observed any conditions that in their judgment may constitute violations of the Food Drug and Cosmetic (FD&C) Act and related Acts.
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.